SCHEMBL3417296

SCHEMBL3417296

Cc1c(C(Br)C=O)sc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
PRNP P04156 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
GPR3 P46089 1/20 0.38
ALOX5 P09917 2/20 0.35
HSD11B1 P28845 1/20 0.35
POLB P06746 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6622422 0.80 PRNP (0.41) ALDH1A1PRNPRXFP1GPR3ALOX5
Hydrochloric Acid SCHEMBL5751827 0.79 ALDH1A1 (0.38) ALDH1A1PRNPRXFP1GPR3ALOX5
SCHEMBL5250330 0.78 ROCK1 (0.43) MAPTROCK1CYP2A6L3MBTL1KDM4E
SCHEMBL12425595 0.74 GPR3 (0.46) ALDH1A1PRNPRXFP1GPR3ALOX5
SCHEMBL4093915 0.73 GPR3 (0.44) ALDH1A1PRNPRXFP1GPR3ALOX5
SCHEMBL22320228 0.72 GPR3 (0.40) ALDH1A1PRNPRXFP1GPR3ALOX5
SCHEMBL27599200 0.70 PRNP (0.41) ALDH1A1PRNPRXFP1ALOX5HSD11B1
SCHEMBL157274 0.69 TUBB4A (0.48) ALDH1A1PRNPRXFP1GPR3HSD11B1
SCHEMBL4099685 0.69 GPR3 (0.40) ALDH1A1PRNPRXFP1GPR3ALOX5
SCHEMBL4099681 0.69 GPR3 (0.40) ALDH1A1PRNPRXFP1GPR3ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265606-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2010-12-29 EP disclosed
WO-2009129109-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-10-22 WO disclosed